Kura Oncology, Inc. (KURA) stock
KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.34−0.15 (-2.00%)
Close on Nov 18, 2026Market cap $652.97MP/E –Yield –
Kura Oncology profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Kura Oncology's profit margin for the twelve months ending Sep 30, 2026 was -369.3%. For fiscal 2025 it was -412.9%, against -322.9% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -412.9% | −90.1 |
| FY2024 | Dec 31, 2024 | -322.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -307.4% | +49.8 |
| Q2 FY2026 | Jun 30, 2026 | -327.3% | +105.2 |
| Q1 FY2026 | Mar 31, 2026 | -401.5% | +5.6 |
| Q4 FY2025 | Dec 31, 2025 | -467.2% | – |
| Q3 FY2025 | Sep 30, 2025 | -357.2% | – |
| Q2 FY2025 | Jun 30, 2025 | -432.5% | – |
| Q1 FY2025 | Mar 31, 2025 | -407.1% | – |
See a number that looks wrong?